stars 1 stars 2 stars 3

GlucoModicum is a company transforming glucose monitoring with precise, needle-free magnetohydrodynamic technology. Its proprietary magnetohydrodynamics platform has the potential to radically change how people monitor their health, creating solutions that are precise, accessible and needle-free, empowering people to live healthier lives. The company’s first product is a non-invasive, wearable glucose monitor for patients suffering from diabetes. GlucoModicum was founded in 2018 as a spinout of the University of Helsinki and combines an experienced, multi-disciplinary in-house team with world-class partners to deliver groundbreaking solutions for personal biomarker monitoring. For more information, please visit: www.sofio.health or www.glucomodicum.com

GlucoModicum Ltd Questions

Alejandro Pérez is the Chief Technology Officer and Co-Founder of GlucoModicum Ltd.

37 people are employed at GlucoModicum Ltd.

GlucoModicum Ltd is based in Helsinki, Uusimaa.

The NAICS codes for GlucoModicum Ltd are [33, 334].

The SIC codes for GlucoModicum Ltd are [38, 384].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users